Neuromuscular Blockade Clinical Trial
Official title:
Popliteal Approach to Sciatic Nerve Block Provides Postoperative Analgesia That Is Not Inferior to That of the Infragluteal Approach in Patients Undergoing Unilateral Total Knee Arthroplasty Under Spinal Anesthesia
Study Hypothesis The investigators approach to demonstrate noninferiority of analgesia provided by popliteal block in TKA surgery will be based on a hypothesis of absence of a clinically significant difference in pain visual analogue sores (VAS) between the analgesia provided by the popliteal block and that of the infragluteal sciatic block in TKA surgery patients.
Sciatic nerve block provides clinically significant analgesic benefits following total knee
arthroplasty (TKA). These benefits include a reduction in pain scores and decrease analgesic
requirements.
Despite these benefits, sciatic nerve block has remained among the least performed peripheral
nerve block by anesthesiologists. Some impediments relating to single shot sciatic nerve
block (SSNB) that may cause anesthesiologists to avoid it include, patient discomfort due to
needle passage through dense gluteal or thigh adipose and musculature, and unreliable success
because of difficulty in localizing the sciatic nerve (particularly in obese patients).
Even in the current era of US guidance, sciatic nerve block remains a challenge. Despite its
helpfulness, ultrasound technology remains hindered by an intrinsic limitation: a trade off
between depth of penetration and image resolution; therefore, it works well for superficial
blocks but becomes less useful when deep structures are imaged-ironically where this guidance
is needed most. The challenge of anatomical depth, as in the case of the sciatic nerve, is
one remaining challenge that dictates practical restrictions on the patterns of practice of
ultrasound-guided regional anesthesia.
Actually, the recommendations of the Joint Committee for Education and Training composed of
the American Society of Regional Anesthesia and the European Society of Regional Anesthesia
cite the depth of block resulting in degradation of both ultrasound and needle image as the
first among other causes that increase the level of difficulty of a nerve block.
As the sciatic nerve travels caudally in the body, it becomes more superficial with less
thickness of tissue separating it from skin surface, making distal sciatic nerve block an
attractive alternative. Indeed, both articular branches which provide sensory innervation to
the knee joint as well as its muscular branches which provide innervation to the muscles
surrounding knee joint most commonly arise from the sciatic nerve either at the knee level,
or just above the knee or within the popliteal fossa.
Blockade of the sciatic nerve at the level of the popliteal fossa, commonly termed a
popliteal block, is technically easier to perform than gluteal sciatic block and may even be
associated with less risk of intravascular injection and nerve injury. Indeed, popliteal
block has been reported to provide good postoperative analgesia in total knee replacement and
other major knee surgery. However, the small posterior cutaneous nerve of the thigh, which
supplies only the skin on the back of the thigh and knee, separates from the sciatic nerve
proximally and variably in the gluteal region, and will be spared in more distal approaches.
It is for this reason why many practitioners are hesitant to perform distal sciatic nerve
blocks for TKA. However, the relative importance of the posterior cutaneous nerve of the
thigh for post-operative analgesia following TKA is unknown and maybe clinically
insignificant.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05558969 -
The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex
|
N/A | |
| Completed |
NCT03168308 -
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
|
Phase 4 | |
| Not yet recruiting |
NCT03978780 -
Erector Spinae Block vs. Placebo Block Study
|
N/A | |
| Completed |
NCT02912039 -
Electromyographic Assessment of the TetraGraph in Normal Volunteers
|
||
| Completed |
NCT02892045 -
Mindray Neuromuscular Transmission Transducer
|
||
| Completed |
NCT03427385 -
Minimum Local Anesthetic Dose for Adductor Canal Block
|
N/A | |
| Completed |
NCT01450813 -
The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy
|
N/A | |
| Completed |
NCT00535496 -
Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)
|
Phase 3 | |
| Recruiting |
NCT05794503 -
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
|
Early Phase 1 | |
| Not yet recruiting |
NCT05993390 -
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
|
N/A | |
| Recruiting |
NCT04609410 -
Bleeding in Laparoscopic Liver Surgery
|
N/A | |
| Terminated |
NCT03649672 -
The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor
|
N/A | |
| Completed |
NCT05474638 -
Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery
|
N/A | |
| Completed |
NCT05687253 -
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
|
Phase 2 | |
| Completed |
NCT05120999 -
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
|
||
| Completed |
NCT03608436 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery
|
Phase 4 | |
| Completed |
NCT03572413 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
|
Phase 4 | |
| Recruiting |
NCT02930629 -
Residual Block in Postoperative Anaesthetic Care Unit
|
N/A | |
| Completed |
NCT02932254 -
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
|
Phase 4 | |
| Completed |
NCT01828385 -
Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex
|
Phase 4 |